You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for amoxicillin; omeprazole magnesium; rifabutin and what is the scope of freedom to operate?

Amoxicillin; omeprazole magnesium; rifabutin is the generic ingredient in one branded drug marketed by Redhill and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Amoxicillin; omeprazole magnesium; rifabutin has twenty-nine patent family members in twenty-four countries.

One supplier is listed for this compound.

Summary for AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN
International Patents:29
US Patents:5
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
DailyMed Link:AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN at DailyMed
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN
Generic Entry Date for AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN*:
Constraining patent/regulatory exclusivity:
GENERATING ANTIBIOTIC INCENTIVES NOW
Dosage:
CAPSULE, DELAYED RELEASE;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

US Patents and Regulatory Information for AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Redhill TALICIA amoxicillin; omeprazole magnesium; rifabutin CAPSULE, DELAYED RELEASE;ORAL 213004-001 Nov 1, 2019 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Redhill TALICIA amoxicillin; omeprazole magnesium; rifabutin CAPSULE, DELAYED RELEASE;ORAL 213004-001 Nov 1, 2019 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Redhill TALICIA amoxicillin; omeprazole magnesium; rifabutin CAPSULE, DELAYED RELEASE;ORAL 213004-001 Nov 1, 2019 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.